4.6 Article

NGF nanoparticles enhance the potency of transplanted human umbilical cord mesenchymal stem cells for myocardial repair

出版社

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpheart.00855.2020

关键词

fibrin patch; human umbilical cord mesenchymal stem cells; myocardial infarction; nerve growth factor; PLGA nanoparticles

资金

  1. National Key Research and Development Program of China [2017YFA0105600, 2020YFA0112600]
  2. National Natural Sciences Foundation of China [81870208, 82070260]
  3. Shanghai Pujiang Program [19PJ1408900]
  4. Science and Technology Development Fund of Shanghai Pudong New Area Grant [PKJ2020-Y23]
  5. Science and Technology Committee of Shanghai Municipality [17431906600]
  6. Major Program of Development Fund for Shanghai Zhangjiang National Innovation Demonstration Zone [ZJ2018-ZD-004]
  7. Shanghai Engineering Research Center of Artificial Heart and Heart Failure Medicine [19DZ2251000]
  8. Peak Disciplines (Type IV) of Institutions of Higher Learning in Shanghai

向作者/读者索取更多资源

NGF PLGA nanoparticles can protect hUCMSCs and promote their paracrine effects through the TrkA-PI3K/Akt signaling pathway, similar to free NGF. The application of NGF PLGA nanoparticles in hUCMSC fibrin cardiac patches significantly improves the retention of transplanted hUCMSCs and enhances their ability to reduce myocardial apoptosis and promote angiogenesis in the mouse heart after MI.
In this study, we investigated whether human umbilical cord mesenchymal stem cell (hUCMSC) fibrin patches loaded with nerve growth factor (NGF) poly(lactic-co-glycolic acid) (PLGA) nanoparticles could enhance the therapeutic potency of hUCMSCs for myocardial infarction (MI). In vitro, NGF significantly improved the proliferation of hUCMSCs and mitigated cytotoxicity and apoptosis under hypoxic injury. NGF also promoted the paracrine effects of hUCMSCs on angiogenesis and cardiomyocyte protection. The tyrosine kinase A (TrkA) and phosphoinositide 3-kinase (PI3K)-serine/threonine protein kinase (Akt) signaling pathways in hUCMSCs were involved in the NGF-induced protection. NGF PLGA nanoparticles continued to release NGF for at least 1 mo and also exerted a protective effect on hUCMSCs, the same with free NGF. In vivo, we treated MI mice with nothing (MI group), a cell-free fibrin patch with blank PLGA nanoparticles (MI + OP group), a cell-free fibrin patch with NGF nanoparticles (MI + NGF group), and hUCMSC fibrin patches with blank PLGA nanoparticles (MI + MSC group) or NGF PLGA nanoparticles (MSC + NGF group). Among these groups, the MSC + NGF group exhibited the best cardiac contractile function, the smallest infarct size, and the thickest ventricular wall. The application of NGF PLGA nanoparticles significantly improved the retention of transplanted hUCMSCs and enhanced their ability to reduce myocardial apoptosis and promote angiogenesis in the mouse heart after MI. These findings demonstrate the promising therapeutic potential of hUCMSC fibrin cardiac patches loaded with NGF PLGA nanoparticles. NEW & NOTEWORTHY NGF PLGA nanoparticles can exert a protective effect on hUCMSCs and promote the paracrine effects of hUCMSCs on angiogenesis and cardiomyocyte protection through TrkA-PI3K/Akt signaling pathway, the same with free NGF. The application of NGF PLGA nanoparticles in the hUCMSC fibrin cardiac patches can significantly improve the retention of transplanted hUCMSCs and enhance their ability to reduce myocardial apoptosis and promote angiogenesis in the mouse heart after MI.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据